Charles Berkman

Currently holds a position at Ligand Pharmaceuticals Inc

Position	Company	Period
Senior Vice President, General Counsel, Secretary	Ligand Pharmaceuticals Inc	Jan. 1, 2018 -
Vice President, General Counsel, Secretary	Ligand Pharmaceuticals Inc	April 1, 2007 - Jan. 1, 2018

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value	Details
2025-02-19	2025-02-19	OmniAb Inc (OABI)	S Sale	7,255 -2.0% 3.67 USD 26,626	7,255 -2.0%	3.67	USD 26,626
2025-02-19	2025-02-18	OmniAb Inc (OABI)	S Sale	8,215 -2.2% 3.68 USD 30,231	8,215 -2.2%	3.68	USD 30,231
2025-01-22	2025-01-21	OmniAb Inc (OABI)	S Sale	25,489 -6.9% 3.24 USD 82,584	25,489 -6.9%	3.24	USD 82,584
2024-12-10	2024-12-09	OmniAb Inc (OABI)	S Sale	8,022 -2.4% 4.13 USD 33,131	8,022 -2.4%	4.13	USD 33,131
2024-04-09	2024-04-08	OmniAb Inc (OABI)	S Sale	6,954 -2.3% 5.27 USD 36,648	6,954 -2.3%	5.27	USD 36,648
2021-02-05	2021-02-04	Ligand Pharmaceuticals Inc (LGND)	S Sale	18,097 -38.5% 178.50 USD 3,230,376	18,097 -38.5%	178.50	USD 3,230,376
2020-06-05	2020-06-04	Ligand Pharmaceuticals Inc (LGND)	S Sale	11,146 -21.4% 118.59 USD 1,321,775	11,146 -21.4%	118.59	USD 1,321,775